Home Stocks ASX HLS:HEALIUS LIMITED
Listed Company

Healius Ltd (ASX HLS)

Followers 61
Exchange ASX
Sector Health Care
Industry Health Care Equipment & Services

Watch

5 high conviction calls from 2022's top-performing fund managers

Livewire Markets

Latest on HEALIUS LIMITED

Daily Report

The Match Out: UBS rescues CS, but market concerns remain

The daily Match Out for Monday 20 March with Market Matters' James Gerrish.
James Gerrish
Market Matters
Equities

Macro explanations don't hold water in small caps (and these stocks prove it)

Macro theses can only take you so far.
David Thornton
Livewire Markets
Equities

FNArena reporting season monitor: February 2023 – Final wrap-up (345 stocks covered)

Ratings, consensus price targets, and FNArena insights on each stock covered feature in the following article
Rudi Filapek-Vandyck
FNArena
Equities

Follow the earnings revisions: Why Macquarie is backing these 13 ASX stocks

Reporting season is like a flash in the pan. What do investors do after the rush is over? Macquarie has some ideas.
Hans Lee
Livewire Markets
Macro

The Macro backdrop remains so important for equities

If the bond market is correct, two more rate hikes will take the cash rate to 4% for the first time in well over a decade.
James Gerrish
Market Matters

Covering Healius Ltd

Bell Potter
Stockbroker
Livewire Exclusive
Livewire Markets
James Gerrish
Market Matters
Rudi Filapek-Vandyck
FNArena
Tim Kelley
Montgomery Investment Management
Buy Hold Sell
Livewire Markets

Healius Ltd (ASX:HLS) is an Australian publicly listed company that trades on the Australian Stock Exchange. The company's stock code is HLS. Livewire Markets has 22 experts who have published 61 articles that have featured Healius Ltd. You can view all those wires here. The last time time HLS was featured was on the 20 March 2023 by James Gerrish in the wire “The Match Out: UBS rescues CS, but market concerns remain”.